---
title: A Study to Assess the Impact of Implementing Modified Early Warning Score in Terms of Competency and Self-efficacy of Nurses at ILBS, Delhi
nct_id: NCT05088044
overall_status: UNKNOWN
phase: NA
sponsor: Institute of Liver and Biliary Sciences, India
study_type: INTERVENTIONAL
primary_condition: Liver Diseases
countries: India
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT05088044.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT05088044"
ct_last_update_post_date: 2022-04-08
last_seen_at: "2026-05-12T07:22:33.813Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# A Study to Assess the Impact of Implementing Modified Early Warning Score in Terms of Competency and Self-efficacy of Nurses at ILBS, Delhi

**Official Title:** A Quasi Experimental Study to Assess the Impact of Implementing Modified Early Warning Score in Terms of Competency and Self-efficacy of Nurses at ILBS, Delhi

**NCT ID:** [NCT05088044](https://clinicaltrials.gov/study/NCT05088044)

## Key Facts

- **Status:** UNKNOWN
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 82
- **Lead Sponsor:** Institute of Liver and Biliary Sciences, India
- **Conditions:** Liver Diseases
- **Start Date:** 2021-11-11
- **Completion Date:** 2022-04-15
- **CT.gov Last Update:** 2022-04-08

## Brief Summary

In this study nurses will be taught regarding Modified Early Warning Score and how to mark the involved physiological parameters in the MEWS chart and then scoring will be given i.e MEWS score and according to the score intervention would be taken by nurses by communicating with other health team members. this scoring will allow nurses to assess early deterioration and early ICU admission and at last nurses will be asked regarding the barriers or facilitators they faced while performing MEWS score.

## Eligibility

- **Minimum age:** 21 Years
- **Maximum age:** 60 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* registered nurses working in general, semi-private and private ward nurses willing to participate

Exclusion Criteria:

* registered nurses who will not be present at the time of data collection. pull out staffs.
```

## Arms

- **staff nurses** (EXPERIMENTAL) — firstly pre-test would conducted for the group then after 7 days post-test would be conducted for the same group intervention which will be given: training on modified early warning score to staff nurses and marking of physiological parameters on MEWS chart

## Interventions

- **training porogram** (OTHER) — training on modified early warning signs will be given to staff nurses and they will be asked to mark physiological parameters on MEWS chart and identify detrioration

## Primary Outcomes

- **to assess the impact of MEWS on competency and self-efficacy of nurses before and after implementing MEWS** _(time frame: 7 days)_ — pre-test would be taken to assess previous level and post-test to measure the change in competency

## Locations (1)

- Institute of Liver & Biliary Sciences, New Delhi, National Capital Territory of Delhi, India — _RECRUITING_

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.institute of liver & biliary sciences|new delhi|national capital territory of delhi|india` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT05088044.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT05088044*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*